Reviews Intron A


No reviews yet.

Intron A Drug Description
INTRON® A
(interferon alfa-2b, recombinant) For Injection

WARNING
Alpha interferons, including INTRON® A, cause or aggravate fatal or life-threatening
neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should
be monitored closely with periodic clinical and laboratory evaluations. Patients
with persistently severe or worsening signs or symptoms of these conditions
should be withdrawn from therapy. In many but not all cases these disorders
resolve after stopping INTRON A therapy. See WARNINGS
and ADVERSE REACTIONS.

DRUG DESCRIPTION



What are the possible side effects of interferon alfa-2b (Intron A)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using interferon alfa-2b and call your doctor at once if you have a serious side effect such as:

severe depression, aggressive behavior, or thoughts of hurting yourself or others;
fast, slow, or uneven heart rate;
feeling like you might pass out;
fever, chills, body aches, flu...
Read All Potential Side Effects for Intron A »




INTRON® A (Interferon alfa-2b) for intramuscular, subcutaneous, intralesional,
or intravenous Injection is a purified sterile recombinant interferon product.
INTRON® A recombinant for Injection has been classified as an alpha interferon
and is a water-soluble protein with a molecular weight of 19,271 daltons produced
by recombinant DNA techniques. It is obtained from the bacterial fermentation
of a strain of Escherichia coli bearing a genetically engineered plasmid
containing an interferon alfa-2b gene from human leukocytes. The fermentation
is carried out in a defined nutrient medium containing the antibiotic tetracycline
hydrochloride at a concentration of 5 to 10 mg/L; the presence of this antibiotic
is not detectable in the final product. The specific activity of Interferon
alfa-2b, recombinant is approximately 2.6 x 108IU/mg protein as measured
by the HPLC assay.
Powder for Injection



Vial Strength Million IU
mL Diluent
Final Concentration after Reconstitution million
IU/mL*
mg INTRON A† per vial
Route of Administration


10
1
10
0.038
IM, SC, IV, IL


18
1
18
0.069
IM, SC, IV


50
1
50
0.192
IM, SC, IV


*Each mL also contains 20 mg glycine, 2.3 mgsodium phosphate
dibasic, 0.55 mg sodium phosphate monobasic, and 1.0 mg human albumin.
†Based on the specific activity of approximately 2.6 x 108IU/mg protein,
as measured by HPLC assay.



Prior to administration, the INTRON A Powder for Injection is to be reconstituted
with the provided Diluent for INTRON A (Sterile Water for Injection, USP) (see
DOSAGE AND ADMINISTRATION). INTRON A Powder for Injection is a white
to cream-colored powder.
Solution Vials for Injection



Vial Strength
Concentration*
mg INTRON A† per vial
Route of Administration


18‡ MIU multidose
3 million IU/0.5 mL
0.088
IM, SC


25¶ MIU multidose
5 million IU/0.5 mL
0.123
IM, SC, IL


*Each mL contains 7.5 mg sodium chloride, 1.8 mg sodium phosphate
dibasic, 1.3 mg sodium phosphate monobasic, 0.1 mg edetate disodium, 0.1
mg polysorbate 80, and 1.5 mg m-cresol as a preservative.
†Based on the specific activity of approximately 2.6 x 108 IU/mg protein
as measured by HPLC assay.
‡This is a multidose vial which contains a total of 22.8 million IU of interferon
alfa-2b, recombinant per 3.8 mL in order to provide the delivery of six
0.5-mL doses, each containing 3 million IU of INTRON A (for a label strength
of 18 million IU).
¶This is a multidose vial which contains a total of 32.0 million
IU of interferon alfa-2b, recombinant per 3.2 mL in order to provide the
delivery of five 0.5-mL doses, each containing 5 million IU of INTRON A
(for a label strength of 25 million IU).



Solution in Multidose Pens for Injection



Pen Strength
Concentration* Million IU/1.5ml
INTRON A Dose Delivered (6 doses, 0.2 mL each)
mg INTRON A† per 1.5 mL
Route of Administration


3MIU
22.5
3 MIU/0.2ml
0.087
SC


5 MIU
37.5
5 MIU/0.2ml
0.144
SC


10 MIU
75
10 MIU/0.2ml
0.288
SC


* Each mL also contains 7.5 mg sodium chloride, 1.8 mg sodium
phosphate dibasic, 1.3 mg sodium phosphate monobasic, 0.1 mg edetate disodium,
0.1 mg polysorbate 80, and 1.5 mg m-cresol asa preservative.
†Based on the specific activity of approximately 2.6 x 108IU/mg protein
as measured by HPLC assay.



These packages do not require reconstitution prior to administration (see DOSAGE
AND ADMINISTRATION). INTRON A Solution for Injection is a clear, colorless
solution.Last reviewed on RxList: 7/8/2008




Intron A Drug Description
INTRON® A
(interferon alfa-2b, recombinant) For Injection

WARNING
Alpha interferons, including INTRON® A, cause or aggravate fatal or life-threatening
neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should
be monitored closely with periodic clinical and laboratory evaluations. Patients
with persistently severe or worsening signs or symptoms of these conditions
should be withdrawn from therapy. In many but not all cases these disorders
resolve after stopping INTRON A therapy. See WARNINGS
and ADVERSE REACTIONS.

DRUG DESCRIPTION



What are the possible side effects of interferon alfa-2b (Intron A)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using interferon alfa-2b and call your doctor at once if you have a serious side effect such as:

severe depression, aggressive behavior, or thoughts of hurting yourself or others;
fast, slow, or uneven heart rate;
feeling like you might pass out;
fever, chills, body aches, flu...
Read All Potential Side Effects for Intron A »




INTRON® A (Interferon alfa-2b) for intramuscular, subcutaneous, intralesional,
or intravenous Injection is a purified sterile recombinant interferon product.
INTRON® A recombinant for Injection has been classified as an alpha interferon
and is a water-soluble protein with a molecular weight of 19,271 daltons produced
by recombinant DNA techniques. It is obtained from the bacterial fermentation
of a strain of Escherichia coli bearing a genetically engineered plasmid
containing an interferon alfa-2b gene from human leukocytes. The fermentation
is carried out in a defined nutrient medium containing the antibiotic tetracycline
hydrochloride at a concentration of 5 to 10 mg/L; the presence of this antibiotic
is not detectable in the final product. The specific activity of Interferon
alfa-2b, recombinant is approximately 2.6 x 108IU/mg protein as measured
by the HPLC assay.
Powder for Injection



Vial Strength Million IU
mL Diluent
Final Concentration after Reconstitution million
IU/mL*
mg INTRON A† per vial
Route of Administration


10
1
10
0.038
IM, SC, IV, IL


18
1
18
0.069
IM, SC, IV


50
1
50
0.192
IM, SC, IV


*Each mL also contains 20 mg glycine, 2.3 mgsodium phosphate
dibasic, 0.55 mg sodium phosphate monobasic, and 1.0 mg human albumin.
†Based on the specific activity of approximately 2.6 x 108IU/mg protein,
as measured by HPLC assay.



Prior to administration, the INTRON A Powder for Injection is to be reconstituted
with the provided Diluent for INTRON A (Sterile Water for Injection, USP) (see
DOSAGE AND ADMINISTRATION). INTRON A Powder for Injection is a white
to cream-colored powder.
Solution Vials for Injection



Vial Strength
Concentration*
mg INTRON A† per vial
Route of Administration


18‡ MIU multidose
3 million IU/0.5 mL
0.088
IM, SC


25¶ MIU multidose
5 million IU/0.5 mL
0.123
IM, SC, IL


*Each mL contains 7.5 mg sodium chloride, 1.8 mg sodium phosphate
dibasic, 1.3 mg sodium phosphate monobasic, 0.1 mg edetate disodium, 0.1
mg polysorbate 80, and 1.5 mg m-cresol as a preservative.
†Based on the specific activity of approximately 2.6 x 108 IU/mg protein
as measured by HPLC assay.
‡This is a multidose vial which contains a total of 22.8 million IU of interferon
alfa-2b, recombinant per 3.8 mL in order to provide the delivery of six
0.5-mL doses, each containing 3 million IU of INTRON A (for a label strength
of 18 million IU).
¶This is a multidose vial which contains a total of 32.0 million
IU of interferon alfa-2b, recombinant per 3.2 mL in order to provide the
delivery of five 0.5-mL doses, each containing 5 million IU of INTRON A
(for a label strength of 25 million IU).



Solution in Multidose Pens for Injection



Pen Strength
Concentration* Million IU/1.5ml
INTRON A Dose Delivered (6 doses, 0.2 mL each)
mg INTRON A† per 1.5 mL
Route of Administration


3MIU
22.5
3 MIU/0.2ml
0.087
SC


5 MIU
37.5
5 MIU/0.2ml
0.144
SC


10 MIU
75
10 MIU/0.2ml
0.288
SC


* Each mL also contains 7.5 mg sodium chloride, 1.8 mg sodium
phosphate dibasic, 1.3 mg sodium phosphate monobasic, 0.1 mg edetate disodium,
0.1 mg polysorbate 80, and 1.5 mg m-cresol asa preservative.
†Based on the specific activity of approximately 2.6 x 108IU/mg protein
as measured by HPLC assay.



These packages do not require reconstitution prior to administration (see DOSAGE
AND ADMINISTRATION). INTRON A Solution for Injection is a clear, colorless
solution.Last reviewed on RxList: 7/8/2008




Intron A Drug Description
INTRON® A
(interferon alfa-2b, recombinant) For Injection

WARNING
Alpha interferons, including INTRON® A, cause or aggravate fatal or life-threatening
neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should
be monitored closely with periodic clinical and laboratory evaluations. Patients
with persistently severe or worsening signs or symptoms of these conditions
should be withdrawn from therapy. In many but not all cases these disorders
resolve after stopping INTRON A therapy. See WARNINGS
and ADVERSE REACTIONS.

DRUG DESCRIPTION



What are the possible side effects of interferon alfa-2b (Intron A)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using interferon alfa-2b and call your doctor at once if you have a serious side effect such as:

severe depression, aggressive behavior, or thoughts of hurting yourself or others;
fast, slow, or uneven heart rate;
feeling like you might pass out;
fever, chills, body aches, flu...
Read All Potential Side Effects for Intron A »




INTRON® A (Interferon alfa-2b) for intramuscular, subcutaneous, intralesional,
or intravenous Injection is a purified sterile recombinant interferon product.
INTRON® A recombinant for Injection has been classified as an alpha interferon
and is a water-soluble protein with a molecular weight of 19,271 daltons produced
by recombinant DNA techniques. It is obtained from the bacterial fermentation
of a strain of Escherichia coli bearing a genetically engineered plasmid
containing an interferon alfa-2b gene from human leukocytes. The fermentation
is carried out in a defined nutrient medium containing the antibiotic tetracycline
hydrochloride at a concentration of 5 to 10 mg/L; the presence of this antibiotic
is not detectable in the final product. The specific activity of Interferon
alfa-2b, recombinant is approximately 2.6 x 108IU/mg protein as measured
by the HPLC assay.
Powder for Injection



Vial Strength Million IU
mL Diluent
Final Concentration after Reconstitution million
IU/mL*
mg INTRON A† per vial
Route of Administration


10
1
10
0.038
IM, SC, IV, IL


18
1
18
0.069
IM, SC, IV


50
1
50
0.192
IM, SC, IV


*Each mL also contains 20 mg glycine, 2.3 mgsodium phosphate
dibasic, 0.55 mg sodium phosphate monobasic, and 1.0 mg human albumin.
†Based on the specific activity of approximately 2.6 x 108IU/mg protein,
as measured by HPLC assay.



Prior to administration, the INTRON A Powder for Injection is to be reconstituted
with the provided Diluent for INTRON A (Sterile Water for Injection, USP) (see
DOSAGE AND ADMINISTRATION). INTRON A Powder for Injection is a white
to cream-colored powder.
Solution Vials for Injection



Vial Strength
Concentration*
mg INTRON A† per vial
Route of Administration


18‡ MIU multidose
3 million IU/0.5 mL
0.088
IM, SC


25¶ MIU multidose
5 million IU/0.5 mL
0.123
IM, SC, IL


*Each mL contains 7.5 mg sodium chloride, 1.8 mg sodium phosphate
dibasic, 1.3 mg sodium phosphate monobasic, 0.1 mg edetate disodium, 0.1
mg polysorbate 80, and 1.5 mg m-cresol as a preservative.
†Based on the specific activity of approximately 2.6 x 108 IU/mg protein
as measured by HPLC assay.
‡This is a multidose vial which contains a total of 22.8 million IU of interferon
alfa-2b, recombinant per 3.8 mL in order to provide the delivery of six
0.5-mL doses, each containing 3 million IU of INTRON A (for a label strength
of 18 million IU).
¶This is a multidose vial which contains a total of 32.0 million
IU of interferon alfa-2b, recombinant per 3.2 mL in order to provide the
delivery of five 0.5-mL doses, each containing 5 million IU of INTRON A
(for a label strength of 25 million IU).



Solution in Multidose Pens for Injection



Pen Strength
Concentration* Million IU/1.5ml
INTRON A Dose Delivered (6 doses, 0.2 mL each)
mg INTRON A† per 1.5 mL
Route of Administration


3MIU
22.5
3 MIU/0.2ml
0.087
SC


5 MIU
37.5
5 MIU/0.2ml
0.144
SC


10 MIU
75
10 MIU/0.2ml
0.288
SC


* Each mL also contains 7.5 mg sodium chloride, 1.8 mg sodium
phosphate dibasic, 1.3 mg sodium phosphate monobasic, 0.1 mg edetate disodium,
0.1 mg polysorbate 80, and 1.5 mg m-cresol asa preservative.
†Based on the specific activity of approximately 2.6 x 108IU/mg protein
as measured by HPLC assay.



These packages do not require reconstitution prior to administration (see DOSAGE
AND ADMINISTRATION). INTRON A Solution for Injection is a clear, colorless
solution.Last reviewed on RxList: 7/8/2008




Intron A Drug Description
INTRON® A
(interferon alfa-2b, recombinant) For Injection

WARNING
Alpha interferons, including INTRON® A, cause or aggravate fatal or life-threatening
neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should
be monitored closely with periodic clinical and laboratory evaluations. Patients
with persistently severe or worsening signs or symptoms of these conditions
should be withdrawn from therapy. In many but not all cases these disorders
resolve after stopping INTRON A therapy. See WARNINGS
and ADVERSE REACTIONS.

DRUG DESCRIPTION



What are the possible side effects of interferon alfa-2b (Intron A)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using interferon alfa-2b and call your doctor at once if you have a serious side effect such as:

severe depression, aggressive behavior, or thoughts of hurting yourself or others;
fast, slow, or uneven heart rate;
feeling like you might pass out;
fever, chills, body aches, flu...
Read All Potential Side Effects for Intron A »




INTRON® A (Interferon alfa-2b) for intramuscular, subcutaneous, intralesional,
or intravenous Injection is a purified sterile recombinant interferon product.
INTRON® A recombinant for Injection has been classified as an alpha interferon
and is a water-soluble protein with a molecular weight of 19,271 daltons produced
by recombinant DNA techniques. It is obtained from the bacterial fermentation
of a strain of Escherichia coli bearing a genetically engineered plasmid
containing an interferon alfa-2b gene from human leukocytes. The fermentation
is carried out in a defined nutrient medium containing the antibiotic tetracycline
hydrochloride at a concentration of 5 to 10 mg/L; the presence of this antibiotic
is not detectable in the final product. The specific activity of Interferon
alfa-2b, recombinant is approximately 2.6 x 108IU/mg protein as measured
by the HPLC assay.
Powder for Injection



Vial Strength Million IU
mL Diluent
Final Concentration after Reconstitution million
IU/mL*
mg INTRON A† per vial
Route of Administration


10
1
10
0.038
IM, SC, IV, IL


18
1
18
0.069
IM, SC, IV


50
1
50
0.192
IM, SC, IV


*Each mL also contains 20 mg glycine, 2.3 mgsodium phosphate
dibasic, 0.55 mg sodium phosphate monobasic, and 1.0 mg human albumin.
†Based on the specific activity of approximately 2.6 x 108IU/mg protein,
as measured by HPLC assay.



Prior to administration, the INTRON A Powder for Injection is to be reconstituted
with the provided Diluent for INTRON A (Sterile Water for Injection, USP) (see
DOSAGE AND ADMINISTRATION). INTRON A Powder for Injection is a white
to cream-colored powder.
Solution Vials for Injection



Vial Strength
Concentration*
mg INTRON A† per vial
Route of Administration


18‡ MIU multidose
3 million IU/0.5 mL
0.088
IM, SC


25¶ MIU multidose
5 million IU/0.5 mL
0.123
IM, SC, IL


*Each mL contains 7.5 mg sodium chloride, 1.8 mg sodium phosphate
dibasic, 1.3 mg sodium phosphate monobasic, 0.1 mg edetate disodium, 0.1
mg polysorbate 80, and 1.5 mg m-cresol as a preservative.
†Based on the specific activity of approximately 2.6 x 108 IU/mg protein
as measured by HPLC assay.
‡This is a multidose vial which contains a total of 22.8 million IU of interferon
alfa-2b, recombinant per 3.8 mL in order to provide the delivery of six
0.5-mL doses, each containing 3 million IU of INTRON A (for a label strength
of 18 million IU).
¶This is a multidose vial which contains a total of 32.0 million
IU of interferon alfa-2b, recombinant per 3.2 mL in order to provide the
delivery of five 0.5-mL doses, each containing 5 million IU of INTRON A
(for a label strength of 25 million IU).



Solution in Multidose Pens for Injection



Pen Strength
Concentration* Million IU/1.5ml
INTRON A Dose Delivered (6 doses, 0.2 mL each)
mg INTRON A† per 1.5 mL
Route of Administration


3MIU
22.5
3 MIU/0.2ml
0.087
SC


5 MIU
37.5
5 MIU/0.2ml
0.144
SC


10 MIU
75
10 MIU/0.2ml
0.288
SC


* Each mL also contains 7.5 mg sodium chloride, 1.8 mg sodium
phosphate dibasic, 1.3 mg sodium phosphate monobasic, 0.1 mg edetate disodium,
0.1 mg polysorbate 80, and 1.5 mg m-cresol asa preservative.
†Based on the specific activity of approximately 2.6 x 108IU/mg protein
as measured by HPLC assay.



These packages do not require reconstitution prior to administration (see DOSAGE
AND ADMINISTRATION). INTRON A Solution for Injection is a clear, colorless
solution.Last reviewed on RxList: 7/8/2008




Intron A Drug Description
INTRON® A
(interferon alfa-2b, recombinant) For Injection

WARNING
Alpha interferons, including INTRON® A, cause or aggravate fatal or life-threatening
neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should
be monitored closely with periodic clinical and laboratory evaluations. Patients
with persistently severe or worsening signs or symptoms of these conditions
should be withdrawn from therapy. In many but not all cases these disorders
resolve after stopping INTRON A therapy. See WARNINGS
and ADVERSE REACTIONS.

DRUG DESCRIPTION



What are the possible side effects of interferon alfa-2b (Intron A)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using interferon alfa-2b and call your doctor at once if you have a serious side effect such as:

severe depression, aggressive behavior, or thoughts of hurting yourself or others;
fast, slow, or uneven heart rate;
feeling like you might pass out;
fever, chills, body aches, flu...
Read All Potential Side Effects for Intron A »




INTRON® A (Interferon alfa-2b) for intramuscular, subcutaneous, intralesional,
or intravenous Injection is a purified sterile recombinant interferon product.
INTRON® A recombinant for Injection has been classified as an alpha interferon
and is a water-soluble protein with a molecular weight of 19,271 daltons produced
by recombinant DNA techniques. It is obtained from the bacterial fermentation
of a strain of Escherichia coli bearing a genetically engineered plasmid
containing an interferon alfa-2b gene from human leukocytes. The fermentation
is carried out in a defined nutrient medium containing the antibiotic tetracycline
hydrochloride at a concentration of 5 to 10 mg/L; the presence of this antibiotic
is not detectable in the final product. The specific activity of Interferon
alfa-2b, recombinant is approximately 2.6 x 108IU/mg protein as measured
by the HPLC assay.
Powder for Injection



Vial Strength Million IU
mL Diluent
Final Concentration after Reconstitution million
IU/mL*
mg INTRON A† per vial
Route of Administration


10
1
10
0.038
IM, SC, IV, IL


18
1
18
0.069
IM, SC, IV


50
1
50
0.192
IM, SC, IV


*Each mL also contains 20 mg glycine, 2.3 mgsodium phosphate
dibasic, 0.55 mg sodium phosphate monobasic, and 1.0 mg human albumin.
†Based on the specific activity of approximately 2.6 x 108IU/mg protein,
as measured by HPLC assay.



Prior to administration, the INTRON A Powder for Injection is to be reconstituted
with the provided Diluent for INTRON A (Sterile Water for Injection, USP) (see
DOSAGE AND ADMINISTRATION). INTRON A Powder for Injection is a white
to cream-colored powder.
Solution Vials for Injection



Vial Strength
Concentration*
mg INTRON A† per vial
Route of Administration


18‡ MIU multidose
3 million IU/0.5 mL
0.088
IM, SC


25¶ MIU multidose
5 million IU/0.5 mL
0.123
IM, SC, IL


*Each mL contains 7.5 mg sodium chloride, 1.8 mg sodium phosphate
dibasic, 1.3 mg sodium phosphate monobasic, 0.1 mg edetate disodium, 0.1
mg polysorbate 80, and 1.5 mg m-cresol as a preservative.
†Based on the specific activity of approximately 2.6 x 108 IU/mg protein
as measured by HPLC assay.
‡This is a multidose vial which contains a total of 22.8 million IU of interferon
alfa-2b, recombinant per 3.8 mL in order to provide the delivery of six
0.5-mL doses, each containing 3 million IU of INTRON A (for a label strength
of 18 million IU).
¶This is a multidose vial which contains a total of 32.0 million
IU of interferon alfa-2b, recombinant per 3.2 mL in order to provide the
delivery of five 0.5-mL doses, each containing 5 million IU of INTRON A
(for a label strength of 25 million IU).



Solution in Multidose Pens for Injection



Pen Strength
Concentration* Million IU/1.5ml
INTRON A Dose Delivered (6 doses, 0.2 mL each)
mg INTRON A† per 1.5 mL
Route of Administration


3MIU
22.5
3 MIU/0.2ml
0.087
SC


5 MIU
37.5
5 MIU/0.2ml
0.144
SC


10 MIU
75
10 MIU/0.2ml
0.288
SC


* Each mL also contains 7.5 mg sodium chloride, 1.8 mg sodium
phosphate dibasic, 1.3 mg sodium phosphate monobasic, 0.1 mg edetate disodium,
0.1 mg polysorbate 80, and 1.5 mg m-cresol asa preservative.
†Based on the specific activity of approximately 2.6 x 108IU/mg protein
as measured by HPLC assay.



These packages do not require reconstitution prior to administration (see DOSAGE
AND ADMINISTRATION). INTRON A Solution for Injection is a clear, colorless
solution.Last reviewed on RxList: 7/8/2008





Other reviews about Intron A on wordpress

SALK insertions
  by bethmayers
When we met today, we decided to focus on hexokinase or SUK mutants, because of their (hopefully) interesting phenotypes. Here are the mutant insertions for each type of […]


Regulatory evolution, agriculture, and RNA – a possibly interesting intersection
  by Arthur Hunt
Much of the interest and excitement in the field of “Evo-Devo” today centers on the roles that changes in gene regulation may play in the evolution.  This mechanism […]


Vertex Common Stock: up 31 percent from Secondary Offering Price of $25.50, on September 18, 2008
  by condor
Yesterday, VRTX rose about 16 percent on the day, now up another 6 percent this morning (Just for those keeping score at home, I had predicted a […]


Association of the protein Z intron F G79A gene polymorphism with recurrent pregnancy loss
  by fertstert
To the Editor: We have read with great interest the study by Dossenbach-Glaninger et al demonstrating a significant association between the protein-Z (PZ) intron 79G allele and recurrent pregnancy […]


Lowenstein Has Withdrawn Its Preemption Argument -- in Older Schering Temodar/Intron Class Action
  by condor
It is puzzling that Mr. Rooney -- of Mr. Eakesley's firm -- has withdrawn his preemption arguments in the Temodar/Intron litigation (as a result of the Wyeth v. […]


Intron-mediated enhancement of gene expression
  by Arthur Hunt
Most genes in eukaryotes (well, at least eukaryotes that are not Saccharomyces cerevisiae) possess introns, sequences that are transcribed by RNA polymerase II and subsequently spliced out from […]


Extensive, Recent Intron Gains in Daphnia Populations
  by geneticpickle
http://www.sciencemag.org/cgi/content/full/326/5957/1260 Wenli Li,1,* Abraham E. Tucker,1,* Way Sung,2 W. Kelley Thomas,2 Michael Lynch1 1 Biology Department, Indiana University, Bloomington, IN 47405, USA. 2 Hubbard Center for Genome Studies, University of New […]


Intron Distribution
  by Michael
Let me now provide a couple of clues to support the hypothesis that introns facilitated the evolution of multicellular life. First, as a general rule, introns are far more […]


Another intron clue
  by Michael
Hey, there is one more clue we can add to the mix when considering introns.  Let me quote from Puzzles of the Human Genome: Why Do We Need […]


what is junk DNA
  by tbdi
Many biologists who learn more about DNA,will find the DNA parts which are located betwen those genes and do not contain information.They called them intron.From now on,the function […]



Other reviews about Intron A on web:

Learn about INTRON® A — how it works and what life may be like during treatment. Learn about your condition, too. Find information that can help you feel more in control, more ... Intron A - Shering


Learn about the prescription medication Intron A (Interferon alfa-2b, Recombinant for Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and ... Intron A (Interferon alfa-2b, Recombinant for Injection) Drug ...


Intron-A Summary of Product Characteristics; Nagata S, Taira H, Hall A, et al. (Mar 1980). "Synthesis in E. coli of a polypeptide with human leukocyte interferon activity". Interferon alfa-2b - Wikipedia, the free encyclopedia


An intron is a DNA region within a gene that is not translated into protein. These non-coding sections are transcribed to precursor mRNA (pre-mRNA) and some other RNAs (such as ... Intron - Wikipedia, the free encyclopedia


Accurate, FDA approved Intron A information for healthcare professionals and patients - brought to you by Drugs.com. Intron A Official FDA information, side effects and uses.


intron n. A segment of a gene situated between exons that is removed before translation of messenger RNA and does not function in coding for protein intron: Definition from Answers.com


Physician reviewed Intron A patient information - includes Intron A description, dosage and directions. Intron A medical facts from Drugs.com


Learn about INTRON® A — how it works and what life may be like during treatment. Learn about your condition, too. Find information that can help you feel more in control, more ... What is INTRON® A?


Learn about the prescription medication Intron A - Rebetol (Ribavirin, Interferon Alfa-2b, Recombinant), drug uses, dosage, side effects, drug interactions, warnings, reviews ... Intron A - Rebetol (Ribavirin, Interferon Alfa-2b, Recombinant ...


Find patient medical information for Intron A Inj on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Intron A Inj : Uses, Side Effects, Interactions, Pictures ...





Featured Reviews

Reviews Phenylephrine, Pyrilamine Maleate, and Dextromethorphan HBr

Deconsal DM Drug Description Deconsal® DM (phenylephrine, pyrilamine maleate, and dextromethorphan HBr) Tannate Chewable Tablets DRUG DESCRIPTION Deconsal® DM Tannate Chewable Tablets are an antihistamine/nasal decongestant/antitussive...
Read More  |  Review This
Reviews Rifadin

Rifadin Drug Description RIFADIN® (rifampin) Capsules USP RIFADIN® IV (rifampin) for Injection USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of RIFADIN (rifampin capsules USP)...
Read More  |  Review This
Reviews Timolol Maleate Ophthalmic Solution

Timoptic Drug Description TIMOPTIC® (timolol maleate) Ophthalmic Solution 0.25% AND 0.5% DRUG DESCRIPTION What are the possible side effects of timolol ophthalmic? Get emergency medical help if you have any of these signs of...
Read More  |  Review This
Reviews Dostinex

Dostinex Drug Description DOSTINEX (cabergoline) Tablets DRUG DESCRIPTION What are the possible side effects of cabergoline (Dostinex)? Get emergency medical help if you have any of these signs of an allergic reaction: hives;...
Read More  |  Review This
Reviews Cladribine

Leustatin Drug Description Leustatin® (cladribine) Injection For Intravenous Infusion Only WARNING LEUSTATIN (cladribine) Injection should be administered under the supervision of a qualified physician experienced in the use of...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....